Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,670,432 papers from all fields of science
Search
Sign In
Create Free Account
CR 1505
Known as:
CR-1505
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
loxiglumide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man
J. Jansen
,
M. C. Jebbink
,
B. R. Douglas
,
C. Lamers
European Journal of Clinical Pharmacology
2004
Corpus ID: 32098157
SummaryCholecystokinin (CCK)-receptor antagonists have been reported to inhibit the effects of the hormone on the…
Expand
1997
1997
Endogenous CCK inhibits colonic contractions in unrestrained conscious rats
K. Hayashi
,
S. Kishimoto
,
Masayuki Kannbe
Regulatory Peptides
1997
Corpus ID: 23532115
1996
1996
Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats.
W. Song
,
H. Yamaguchi
,
I. Nakano
,
T. Kimura
,
H. Nawata
Fukuoka igaku zasshi = Hukuoka acta medica
1996
Corpus ID: 22086495
The aim of this study was to investigate the effect of endogenous cholecystokinin (CCK) on pancreatic regeneration after acute…
Expand
1995
1995
Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA
N. Sazaki
,
K. Miyasaka
,
M. Matsumoto
,
A. Funakoshi
Journal of gastroenterology
1995
Corpus ID: 20346636
The effects of the intraduodenal administration of a low dose of CR-1505 for 3–7 days on the gene expression of cholecystokinin…
Expand
1993
1993
Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR‐1505), on the growth of freshly separated and xenografted human pancreatic cancer
H. Morimoto
,
Y. Nio
,
+8 authors
T. Tobe
Journal of Surgical Oncology
1993
Corpus ID: 25343018
The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR‐1505), on four freshly separated and six xenografted…
Expand
1990
1990
Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig
G. Morini
,
E. Barocelli
,
M. Impicciatore
,
J. Grider
,
G. Makhlouf
Regulatory Peptides
1990
Corpus ID: 13377007
1989
1989
CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
J. Konturek
,
S. Konturek
,
A. Kurek
,
J. Bogdał
,
J. Oleksy
,
L. Rovati
Gut
1989
Corpus ID: 16737880
The postprandial contractions of the gall bladder result from the interaction of neurohormonal factors but their relative…
Expand
1989
1989
The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.
B. R. Douglas
,
Max C.W. Jebbink
,
Richenel T.O. Tjon A Tham
,
J. Jansen
,
Cornelis B.H.W. Lamers
European Journal of Pharmacology
1989
Corpus ID: 4541161
1987
1987
Loxiglumide protects against experimental pancreatitis.
I. Setnikar
,
M. Bani
,
+4 authors
L. Revel
Arzneimittel-Forschung
1987
Corpus ID: 25406548
Loxiglumide (D,L-4-(3,4-dichloro-benzoylamino)- 5-(N-3-methoxypropyl-pentylamino)-5-oxo-pentanoic acid, CR 1505) is a derivative…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE